Follow-up younger patient with anti-NMDA-R encephalitis

Anti-NMDA-R encephalitis: follow-up of 24 months

Anti-N-methyl-D-aspartate receptor (anti-NMDA-R) encephalitis is the second-most-common cause of autoimmune encephalitis, based on epidemiological studies.It has been predominantly described in young females, with prominent psychiatric symptoms, memory loss, decrease in level of consciousness, epilepsy, and central hypoventilation. The condition is commonly associated with mature ovarian terato...

O 17: Childhood Anti-NMDA Receptor Encephalitis

Anti N-methyl-D-aspartate receptor (NMDR) encephalitis has been recognized as the most frequent autoimmune encephalitis in children after acute demyelinating encephalomyelitis (ADEM).However due to the variable the variable clinical presentation, the paucity of specific finding on standard laboratory and radiological investigation remains under recognized. First discribed in 2005, most commonly...

Anti-NMDA receptor encephalitis in a patient with rheumatoid arthritis.

Anti-NMDA Receptor Encephalitis

In recent years, the discovery of antibodies to specific neuronal antigens that then go on to cause encephalitis has gone a long way to change the investigation and management of a potential encephalitic process. These have now become known under the umbrella term of the ‘autoimmune encephalitides’. In this article we look at antiN-methyl-D-aspartate receptor encephalitis, a condition most ofte...

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

BACKGROUND Anti-N-methyl-d-aspartate (NMDA) receptor encephalitis is a severe but treatable autoimmune disorder which diagnosis depends on sensitive and specific antibody testing. We aimed to assess the sensitivity and specificity of serum and CSF antibody testing in patients with anti-NMDA receptor encephalitis, and the relation between titres, relapses, outcome, and epitope repertoire. METH...